US2003017214A1PendingUtilityA1
Stabilized cefuroxime axetil
Priority: Jul 29, 1999Filed: Sep 12, 2002Published: Jan 23, 2003
Est. expiryJul 29, 2019(expired)· nominal 20-yr term from priority
Inventors:Bernard Charles Sherman
A61K 9/1611A61K 31/546A61K 9/1623A61K 9/2009
57
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Solid pharmaceutical compositions comprising cefuroxime axetil as active ingredient and a zinc salt as stabilizer.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A solid pharmaceutical composition comprising cefuroxime axetil and a zinc salt.
2 . A composition of claim 1 , wherein the zinc salt is zinc chloride.
3 . A composition of claim 1 or 2 , wherein the amount of zinc salt is from about 0.1 part to about 4 parts per 100 parts cefuroxime axetil by weight.
4 . A composition of claim 1 or 2 , wherein the amount of zinc salt is from about 0.2 to about 2 parts per 100 parts cefuroxime axetil by weight.
5 . A composition of claim 1 or 2 , wherein the amount of zinc salt is about 1 part per 100 parts cefuroxime axetil by weight.
6 . A composition of any of claims 1 to 5 , in the form of a tablet.
7 . A composition of any of claims 1 to 5 , in the form of powder or granules for oral suspension.
8 . A process of stabilization of cefuroxime axetil comprising the step of addition of a zinc salt to the cefuroxime axetil.
9 . A process of claim 8 , wherein the cefuroxime axetil and zinc salt are both dissolved in solvent and the solvent is evaporated.
10 . A process of claim 8 or 9 , wherein the zinc salt is zinc chloride.Join the waitlist — get patent alerts
Track US2003017214A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.